Under pathological conditions, genetic and pharmacological inhibition of JNK1 can ameliorate oxygen-induced retinopathy (a mouse model of ROP) by regulating the VEGF expression [328]. The gene discussed is VEGFA; the disease is retinopathy of prematurity.